Perspective on Intradiscal Therapies for Lumbar Discogenic Pain: State of the Science, Knowledge Gaps, and Imperatives for Clinical Adoption

References

• Fine N, Lively S, Seguin CA, Perruccio AV, Kapoor M, Rampersaud R. Intervertebral disc degeneration and osteoarthritis: a common molecular disease spectrum. Nat Rev Rheumatol. 2023;19(3):136–152. doi:10.1038/s41584-022-00888-z
   PubMed Web of Science ®Google Scholar
• Lorio MP, Beall DP, Calodney AK, Lewandrowski KU, Block JE, Mekhail N. Defining the patient with lumbar discogenic pain: real-world implications for diagnosis and effective clinical management. J Pers Med. 2023;13(5):821. doi:10.3390/jpm13050821
   PubMed Web of Science ®Google Scholar
• Bogduk N. Degenerative joint disease of the spine. Radiol Clin North Am. 2012;50(4):613–628. doi:10.1016/j.rcl.2012.04.012
   PubMed Web of Science ®Google Scholar
• Bogduk N. On the definitions and physiology of back pain, referred pain, and radicular pain. Pain. 2009;147(1–3):17–19. doi:10.1016/j.pain.2009.08.020
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Pampati V, et al. Evaluation of the relative contributions of various structures in chronic low back pain. Pain Physician. 2001;4(4):308–316. doi:10.36076/ppj.2001/4/308
   PubMedGoogle Scholar
• Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine. 1995;20(17):1878–1883. doi:10.1097/00007632-199509000-00007
   PubMed Web of Science ®Google Scholar
• Her YF, Kubrova E, Martinez Alvarez GA, D’Souza RS. The analgesic efficacy of intradiscal injection of bone marrow aspirate concentrate and culture-expanded bone marrow mesenchymal stromal cells in discogenic pain: a systematic review. J Pain Res. 2022;15:3299–3318. doi:10.2147/JPR.S373345
   PubMed Web of Science ®Google Scholar
• Hickman TT, Rathan-Kumar S, Peck SH. Development, pathogenesis, and regeneration of the intervertebral disc: current and future insights spanning traditional to omics methods. Front Cell Dev Biol. 2022;10:841831. doi:10.3389/fcell.2022.841831
   PubMed Web of Science ®Google Scholar
• Muthu S, Jeyaraman M, Chellamuthu G, Jeyaraman N, Jain R, Khanna M. Does the intradiscal injection of platelet rich plasma have any beneficial role in the management of lumbar disc disease? Global Spine J. 2022;12(3):503–514. doi:10.1177/2192568221998367
   PubMed Web of Science ®Google Scholar
• Peng B, Xu B, Wu W, Du L, Zhang T, Zhang J. Efficacy of intradiscal injection of platelet-rich plasma in the treatment of discogenic low back pain: a single-arm meta-analysis. Medicine. 2023;102(10):e33112. doi:10.1097/MD.0000000000033112
   PubMed Web of Science ®Google Scholar
• Sakai D, Andersson GB. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions. Nat Rev Rheumatol. 2015;11(4):243–256. doi:10.1038/nrrheum.2015.13
   PubMed Web of Science ®Google Scholar
• Sakai D, Schol J, Watanabe M. Clinical development of regenerative medicine targeted for intervertebral disc disease. Medicina. 2022;58(2):267. doi:10.3390/medicina58020267
   PubMedGoogle Scholar
• Schneider BJ, Hunt C, Conger A, et al. The effectiveness of intradiscal biologic treatments for discogenic low back pain: a systematic review. Spine J. 2022;22(2):226–237. doi:10.1016/j.spinee.2021.07.015
   PubMed Web of Science ®Google Scholar
• Schol J, Sakai D. Comprehensive narrative review on the analysis of outcomes from cell transplantation clinical trials for discogenic low back pain. N Am Spine Soc J. 2023;13:100195. doi:10.1016/j.xnsj.2022.100195
   PubMedGoogle Scholar
• Xie B, Chen S, Xu Y, et al. Clinical efficacy and safety of human mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized controlled trials. Stem Cells Int. 2021;2021:9149315. doi:10.1155/2021/9149315
   PubMed Web of Science ®Google Scholar
• Johnson WE, Caterson B, Eisenstein SM, Hynds DL, Snow DM, Roberts S. Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum. 2002;46(10):2658–2664. doi:10.1002/art.10585
   PubMed Web of Science ®Google Scholar
• Johnson WE, Caterson B, Eisenstein SM, Roberts S. Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro. Spine. 2005;30(10):1139–1147. doi:10.1097/01.brs.0000162624.95262.73
   PubMed Web of Science ®Google Scholar
• Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG. The molecular basis of intervertebral disc degeneration. Spine J. 2013;13(3):318–330. doi:10.1016/j.spinee.2012.12.003
   PubMed Web of Science ®Google Scholar
• Alini M, Diwan AD, Erwin WM, Little CB, Melrose J. An update on animal models of intervertebral disc degeneration and low back pain: exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics. JOR Spine. 2023;6(1):e1230. doi:10.1002/jsp2.1230
   PubMedGoogle Scholar
• Setton LA, Chen J. Mechanobiology of the intervertebral disc and relevance to disc degeneration. J Bone Joint Surg Am. 2006;88(Suppl 2):52–57. doi:10.2106/JBJS.F.00001
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. Guidance for industry and Food and Drug Administration staff; 2020.
   Google Scholar
• Coric D, Pettine K, Sumich A, Boltes MO. Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 Joint Spine Section Meeting. J Neurosurg Spine. 2013;18(1):85–95. doi:10.3171/2012.10.SPINE12512
   PubMed Web of Science ®Google Scholar
• Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. Lumbar Intradiskal Platelet-Rich Plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R. 2016;8(1):1–10; quiz 10. doi:10.1016/j.pmrj.2015.08.010
   PubMedGoogle Scholar
• Zielinski MA, Evans NE, Bae H, et al. Safety and Efficacy of platelet rich plasma for treatment of lumbar discogenic pain: a prospective, multicenter, randomized, double-blind study. Pain Physician. 2022;25(1):29–34.
   PubMed Web of Science ®Google Scholar
• Noriega DC, Ardura F, Hernandez-Ramajo R, et al. Treatment of degenerative disc disease with allogeneic mesenchymal stem cells: long-term follow-up results. Transplantation. 2021;105(2):e25–e27. doi:10.1097/TP.0000000000003471
   PubMed Web of Science ®Google Scholar
• Noriega DC, Ardura F, Hernandez-Ramajo R, et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation. 2017;101(8):1945–1951. doi:10.1097/TP.0000000000001484
   PubMed Web of Science ®Google Scholar
• Schulz KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in randomized trials. Ann Intern Med. 2002;136(3):254–259. doi:10.7326/0003-4819-136-3-200202050-00022
   PubMed Web of Science ®Google Scholar
• Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet. 2002;359(9307):696–700. doi:10.1016/S0140-6736(02)07816-9
   PubMed Web of Science ®Google Scholar
• Amirdelfan K, Bae H, McJunkin T, et al. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. Spine J. 2021;21(2):212–230. doi:10.1016/j.spinee.2020.10.004
   PubMed Web of Science ®Google Scholar
• Beall DP, Davis T, DePalma MJ, et al. Viable Disc tissue allograft supplementation; one- and two-level treatment of degenerated intervertebral discs in patients with chronic discogenic low back pain: one year results of the vast randomized controlled trial. Pain Physician. 2021;24(6):465–477.
   PubMed Web of Science ®Google Scholar
• Beall DP, Wilson GL, Bishop R, Tally W. VAST clinical trial: safely supplementing tissue lost to degenerative disc disease. Int J Spine Surg. 2020;14(2):239–253. doi:10.14444/7033
   PubMed Web of Science ®Google Scholar
• Hunter CW, Guyer R, Froimson M, DePalma MJ. Effect of age on outcomes after allogeneic disc tissue supplementation in patients with chronic discogenic low back pain in the VAST trial. Pain Manag. 2022;12(3):301–311. doi:10.2217/pmt-2021-0078
   PubMed Web of Science ®Google Scholar
• Altman RD, Devji T, Bhandari M, Fierlinger A, Niazi F, Christensen R. Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: a systematic review and meta-analysis of randomized trials. Semin Arthritis Rheum. 2016;46(2):151–159. doi:10.1016/j.semarthrit.2016.04.003
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Rael LT, Brody EN. Use of saline as a placebo in intra-articular injections in osteoarthritis: potential contributions to nociceptive pain relief. Open Rheumatol J. 2017;11(1):16–22. doi:10.2174/1874312901711010016
   PubMedGoogle Scholar
• Saltzman BM, Leroux T, Meyer MA, et al. The therapeutic effect of intra-articular normal saline injections for knee osteoarthritis: a meta-analysis of evidence level 1 studies. Am J Sports Med. 2017;45(11):2647–2653. doi:10.1177/0363546516680607
   PubMed Web of Science ®Google Scholar
• Fabre H, Ducret M, Degoul O, et al. Characterization of different sources of human MSCs expanded in serum-free conditions with quantification of chondrogenic induction in 3D. Stem Cells Int. 2019;2019:2186728. doi:10.1155/2019/2186728
   PubMed Web of Science ®Google Scholar
• Mohamed-Ahmed S, Fristad I, Lie SA, et al. Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. Stem Cell Res Ther. 2018;9(1):168. doi:10.1186/s13287-018-0914-1
   PubMedGoogle Scholar
• Williams RJ, Tryfonidou MA, Snuggs JW, Le Maitre CL. Cell sources proposed for nucleus pulposus regeneration. JOR Spine. 2021;4(4):e1175. doi:10.1002/jsp2.1175
   PubMedGoogle Scholar
• Gay MH, Mehrkens A, Rittmann M, et al. Nose to back: compatibility of nasal chondrocytes with environmental conditions mimicking a degenerated intervertebral disc. Eur Cell Mater. 2019;37:214–232. doi:10.22203/eCM.v037a13
   PubMed Web of Science ®Google Scholar
• Vadala G, Sowa G, Hubert M, Gilbertson LG, Denaro V, Kang JD. Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation. J Tissue Eng Regen Med. 2012;6(5):348–355. doi:10.1002/term.433
   PubMed Web of Science ®Google Scholar
• Risbud MV, Schipani E, Shapiro IM. Hypoxic regulation of nucleus pulposus cell survival: from niche to notch. Am J Pathol. 2010;176(4):1577–1583. doi:10.2353/ajpath.2010.090734
   PubMed Web of Science ®Google Scholar
• Colella F, Garcia JP, Sorbona M, et al. Drug delivery in intervertebral disc degeneration and osteoarthritis: selecting the optimal platform for the delivery of disease-modifying agents. J Control Release. 2020;328:985–999. doi:10.1016/j.jconrel.2020.08.041
   PubMed Web of Science ®Google Scholar
• Filler AG. Emergence and optimization of upright posture among hominiform hominoids and the evolutionary pathophysiology of back pain. Neurosurg Focus. 2007;23(1):1–6. doi:10.3171/FOC-07/07/E4
   PubMedGoogle Scholar
• Pennisi E. Evolutionary biology. The burdens of being a biped. Science. 2012;336(6084):974. doi:10.1126/science.336.6084.974
   PubMed Web of Science ®Google Scholar
• Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26(17):1873–1878. doi:10.1097/00007632-200109010-00011
   PubMed Web of Science ®Google Scholar
• Lotz JC, Haughton V, Boden SD, et al. New treatments and imaging strategies in degenerative disease of the intervertebral disks. Radiology. 2012;264(1):6–19. doi:10.1148/radiol.12110339
   PubMed Web of Science ®Google Scholar
• Kushchayev SV, Glushko T, Jarraya M, et al. ABCs of the degenerative spine. Insights Imaging. 2018;9(2):253–274. doi:10.1007/s13244-017-0584-z
   PubMed Web of Science ®Google Scholar
• International Spine Intervention Society. Lumbar disc stimulation (Provocation Discography). In: Bogduk N, editor. Practice Guidelines for Spinal Diagnostic and Treatment Procedures. 1st ed. San Francisco: International Spine Intervention Society; 2004:20–46.
   Google Scholar
• Rossi MJ, Brand JC, Lubowitz JH. Minimally Clinically Important Difference (MCID) is a low bar. Arthroscopy. 2023;39(2):139–141. doi:10.1016/j.arthro.2022.11.001
   PubMed Web of Science ®Google Scholar
• Adindu EK, Singh D, Geck M, Stokes J, Truumees E. Minimal clinically important difference and patient-acceptable symptom state in orthopaedic spine surgery: a review. JBJS Rev. 2023;11(4). doi:10.2106/JBJS.RVW.22.00200
   PubMedGoogle Scholar
• Tubach F, Dougados M, Falissard B, Baron G, Logeart I, Ravaud P. Feeling good rather than feeling better matters more to patients. Arthritis Rheum. 2006;55(4):526–530. doi:10.1002/art.22110
   PubMedGoogle Scholar
• Pham T, Tubach F. Patient acceptable symptomatic state (PASS). Joint Bone Spine. 2009;76(4):321–323. doi:10.1016/j.jbspin.2009.03.008
   PubMed Web of Science ®Google Scholar
• Daste C, Abdoul H, Foissac F, et al. Patient acceptable symptom state for patient-reported outcomes in people with non-specific chronic low back pain. Ann Phys Rehabil Med. 2022;65(1):101451. doi:10.1016/j.rehab.2020.10.005
   PubMed Web of Science ®Google Scholar
• Tubach F, Ravaud P, Martin-Mola E, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and Hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res. 2012;64(11):1699–1707.
   PubMed Web of Science ®Google Scholar
• Ostelo RW, Deyo RA, Stratford P, et al. Interpreting change scores for pain and functional status in low back pain. Towards international consensus regarding minimal important change. Spine. 2008;33(1):90–94. doi:10.1097/BRS.0b013e31815e3a10
   PubMed Web of Science ®Google Scholar
• Glassman SD, Copay AG, Berven SH, Polly DW, Subach BR, Carreon LY. Defining substantial clinical benefit following lumbar spine arthrodesis. J Bone Joint Surg Am. 2008;90(9):1839–1847. doi:10.2106/JBJS.G.01095
   PubMed Web of Science ®Google Scholar
• Power JD, Perruccio AV, Canizares M, et al. Determining minimal clinically important difference estimates following surgery for degenerative conditions of the lumbar spine: analysis of the Canadian Spine Outcomes and Research Network (CSORN) registry. Spine J. 2023;23(9):1323–1333. doi:10.1016/j.spinee.2023.05.001
   PubMed Web of Science ®Google Scholar
• Solberg T, Johnsen LG, Nygaard OP, Grotle M. Can we define success criteria for lumbar disc surgery?: estimates for a substantial amount of improvement in core outcome measures. Acta Orthop. 2013;84(2):196–201. doi:10.3109/17453674.2013.786634
   PubMed Web of Science ®Google Scholar
• Werner DAT, Grotle M, Gulati S, et al. Criteria for failure and worsening after surgery for lumbar disc herniation: a multicenter observational study based on data from the Norwegian Registry for Spine Surgery. Eur Spine J. 2017;26(10):2650–2659. doi:10.1007/s00586-017-5185-5
   PubMed Web of Science ®Google Scholar
• Yin W, Pauza K, Olan WJ, Doerzbacher JF, Thorne KJ. Intradiscal injection of fibrin sealant for the treatment of symptomatic lumbar internal disc disruption: results of a prospective multicenter pilot study with 24-month follow-up. Pain Med. 2014;15(1):16–31. doi:10.1111/pme.12249
   PubMed Web of Science ®Google Scholar
• Beall DP, Amirdelfan K, Nunley PD, Phillips TR, Imaz Navarro LC, Spath A. Hydrogel augmentation of the lumbar intervertebral disc: an early feasibility study of a treatment for discogenic low back pain. J Vasc Interv Radiol. 2024;35(1):51–58 e51. doi:10.1016/j.jvir.2023.09.018
   PubMed Web of Science ®Google Scholar
• Kanan M, Eby O, Kelkar A, et al. Electrical stimulation-mediated tissue healing in porcine intervertebral disc under mechanically dynamic organ culture conditions. Spine. 2022;47(10):764–772. doi:10.1097/BRS.0000000000004331
   PubMed Web of Science ®Google Scholar
• Vadala G, Ambrosio L, Russo F, Papalia R, Denaro V. Stem Cells and intervertebral disc regeneration overview-what they can and can’t do. Int J Spine Surg. 2021;15(s1):40–53. doi:10.14444/8054
   PubMedGoogle Scholar
• Paez A, Rovers M, Hutchison K, et al. Beyond the RCT: when are randomized trials unnecessary for new therapeutic devices, and what should we do instead? Ann Surg. 2022;275(2):324–331. doi:10.1097/SLA.0000000000005053
   PubMed Web of Science ®Google Scholar
• Abraham I, Lewandrowski KU, Elfar JC, et al. Randomized clinical trials and observational tribulations: providing clinical evidence for personalized surgical pain management care models. J Pers Med. 2023;13(7):1044. doi:10.3390/jpm13071044
   PubMed Web of Science ®Google Scholar
• Lewandrowski KU, Leon JF, Dowling A, et al. Breaking through the glass ceiling effect of high-grade clinical evidence creation in orthopaedics & trauma. Revista Colombiana de Ortopedia y Traumatología. 2022;36(4):215–228. doi:10.1016/j.rccot.2022.10.003
   Google Scholar
• Hutchinson N, Moyer H, Zarin DA, Kimmelman J. The proportion of randomized controlled trials that inform clinical practice. Elife. 2022;2:11.
   Google Scholar
• Fanaroff AC, Califf RM, Harrington RA, et al. Randomized trials versus common sense and clinical observation: JACC review topic of the week. J Am Coll Cardiol. 2020;76(5):580–589. doi:10.1016/j.jacc.2020.05.069
   PubMed Web of Science ®Google Scholar